Greytown Advisors Inc. Amgen Inc Transaction History

Greytown Advisors Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$230.71 - $256.74 $290,694 - $323,492	-1,260 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $352,366 - $389,809	-1,607 Reduced 56.05%	1,260 $305,000
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $153,933 - $176,162	774 Added 36.98%	2,867 $645,000
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $444,281 - $520,529	2,093 New	2,093 $445,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Greytown Advisors Inc., based on Form 13F filings with the SEC.

Stay updated on Greytown Advisors Inc. with notifications on news.